RYR1 and dilated cardiomyopathy: These results are consistent with a prior clinical observational study by Münch et al. reporting significantly increased protein expression of RYR1 in the LV of patients with dilated cardiomyopathy and NYHA class IV HF when compared to nonfailing control hearts (20).